Historical record - last NADAC effective date: 6/19/2024
Product Information
CEFPODOXIME 200 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $1.7961 per EA under NDC 67877056020. Its NADAC has been published 88 times since Oct 26, 2022.
FDA first approved this application on May 18, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877056020
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/19/2024
Active Ingredients
CEFPODOXIME PROXETILApproval Type
Generic (ANDA)
FDA Application
ANDA210568FDA Approved
5/18/2022
TE Code
AB
On Market Since
5/19/2022
Pharmacological Classes
Price Statistics
The NADAC for CEFPODOXIME 200 MG TABLET has been published 88 times since Oct 26, 2022, and over the history we have for it it has declined 36.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7961 per EA |
|---|---|
| All-time high | $2.9289 (Dec 14, 2022) |
| All-time low | $1.5899 (Apr 17, 2024) |
| Median price | $2.3903 |
| Average price | $2.4015 |
| Largest weekly change | -33.3% (Apr 17, 2024) |
| Weeks tracked | 88 |
| Tracking since | Oct 26, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-28.1%
5Y
N/A
All
-36.1%
Last surveyed Jun 26, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFPODOXIME 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CEFPODOXIME 200 MG TABLET, manufactured by Ascend Laboratories, LLC, is $1.7961 per EA (NDC 67877056020), effective Jun 26, 2024.
How has the price of CEFPODOXIME 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for CEFPODOXIME 200 MG TABLET has declined 36.1%. It has been tracked across 88 weekly CMS publications since Oct 26, 2022.
What are the highest and lowest recorded NADAC prices for CEFPODOXIME 200 MG TABLET?
Since Oct 26, 2022, the NADAC for CEFPODOXIME 200 MG TABLET has ranged from a low of $1.5899 (Apr 17, 2024) to a high of $2.9289 (Dec 14, 2022), with a median of $2.3903 per EA.
Are there cheaper alternatives to CEFPODOXIME 200 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFPODOXIME 200 MG TABLET, is $1.3457 per EA — about 25% below CEFPODOXIME 200 MG TABLET.
Who manufactures CEFPODOXIME 200 MG TABLET?
CEFPODOXIME 200 MG TABLET (NDC 67877056020) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.